Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Medication safety of prescription in pregnant women with constipation

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Poster
  • By: HUANG, Shu Fen (Chi-Mei medical center, Pharmacy, Tainan, China Taiwan)
  • Co-author(s): Shu Fen Huang:
  • Abstract:

    The prevalence of constipation in pregnancy ranges from 11% to 44%. Common medications like lubricants, bulk-forming agents, osmotic laxatives, stimulant laxatives, stool softeners, and enemas and suppositories are not necessarily suitable for use in pregnant women. FDA categorized the risks of taking a drug or biological product during pregnancy..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses